Biotech Opportunities: Look for Decent Pipeline, Big Pharma Partnerships [View article]
CTIC is clearly a safe pick. With the run its had and the news on PIX, an investor will always be available. Now GNTA is another story, but a nice little gamble with a small position.
Sort by:
Latest | Highest ratedHemispherx's Ampligen: Fact vs. Fiction [View article]
Hemispherx Biopharma: Hot and Likely to Get Hotter [View article]
Biotech Opportunities: Look for Decent Pipeline, Big Pharma Partnerships [View article]